TPIA 0.15 Mycotopia Therapies, Inc.
| Range: | 0.013-0.18 | Vol Avg: | 5021 | Last Div: | 0 | Changes: | -0.01 |
| Beta: | 2.53 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Fri Mar 31 2006 | Empoloyees: | 1 | ||
| CUSIP: | 62846W107 | CIK: | 0001763329 | ISIN: | US62846W1071 | Country: | US |
| CEO: | Mr. Benjamin Kaplan | Website: | https://www.mycotopiatherapies.com | ||||
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow